Related Experiment Video

Updated: Oct 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Correction to: Association between heart rate variability and striatal dopamine depletion in Parkinson's disease

Tomomichi Kitagawa1, Tadashi Umehara2, Hisayoshi Oka3

  • 1Departments of Neurology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan.

Journal of Neural Transmission (Vienna, Austria : 1996)
|October 19, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K

Related Experiment Videos

Last Updated: Oct 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

444
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
444
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

840
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
840
Neural Regulation01:37

Neural Regulation

40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K

Articles linked to this work by shared authors, journal, and citation graph.

"Abductor Sparing": A New Selective Involvement in ALS.

Muscle & nerve·2026

Prognostic value of acylcarnitine-to-free carnitine ratio in ischemic stroke: associations with systemic inflammation and atherosclerosis.

European journal of clinical nutrition·2026

Cardiac Sympathetic Dysfunction Reveals Asymmetric Dopaminergic Neurodegeneration in Drug-naive Parkinson Disease.

Clinical nuclear medicine·2026

Characteristics of patients with cryptogenic stroke and atrial fibrillation detected using insertable cardiac monitoring in the chronic phase: a subanalysis of the LOOK study.

Frontiers in neurology·2026

Three-year real-world effectiveness, treatment persistence, and planned discontinuation of anti-calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a single-center cohort from Japan.

Frontiers in neurology·2026

Preserved cardiovascular autonomic function predicts the response to initial MAO-B inhibitor treatment in Parkinson's disease.

Parkinsonism & related disorders·2026

Lifestyle medicine for neuroprotection: evidence and implementation in Asian contexts.

Journal of neural transmission (Vienna, Austria : 1996)·2026

The BDNF-mediated association between NGAL and cognitive function in drug-naïve schizophrenia.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Concomitant pathologies and their impact on schizophrenia: a narrative overview of current evidence.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Stress and Parkinson's disease: from dysfunctional detection to impaired handling: a narrative review.

Journal of neural transmission (Vienna, Austria : 1996)·2026

On-demand therapies-emergency medication or daily routine?

Journal of neural transmission (Vienna, Austria : 1996)·2026

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches.

Clinical pharmacology and therapeutics·2026

Atorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk Management.

Cardiovascular therapeutics·2026

Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New Zealand.

Drug safety·2026

Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study.

Journal of affective disorders·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us